Schedule 13G ownership disclosure

BIOXCEL THERAPEUTICS INC

Security class unavailable · CUSIP: 09075P105

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,020,000
Percent of class
37.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-024376
Form type
SC 13G/A
Filer
BioXcel Holdings, Inc.
CIK
CIK 1811154
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub